Peer-reviewed veterinary case report
Neurological reaction in Australian Shepherd after Profender treatment
By Daniela Gaens et al.·Published in Frontiers in Veterinary Science·2019·Faculty of Veterinary Medicine, Institute of Pharmacology and Toxicology, Justus Liebig University Giessen, Giessen, Germany, CH·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Adverse Drug Reactions After Administration of Emodepside/Praziquantel (Profender®) in an MDR1-Mutant Australian Shepherd Dog: Case Report
- Species:
- dog
Plain-English summary
A 3-year-old male Australian Shepherd experienced serious neurological symptoms, including tremors, agitation, and panting, after receiving the flea and tick treatment Profender® at the recommended dose. The owner had not followed the manufacturer's advice to fast the dog before treatment, which may have contributed to the adverse reaction. The dog required hospitalization, but thankfully all symptoms resolved within 24 hours with supportive care, and he was sent home without needing further medication. This case highlights the importance of following dosing instructions and considering genetic factors, as this breed can have a mutation that affects how they process certain medications.
People also search for: Australian Shepherd neurological symptoms after Profender · dog tremors after flea treatment · Profender side effects in dogs
Abstract
A 3-year-old male Australian Shepherd was presented with signs of neurological toxicity following the administration of Profender® at the recommended dosage. Unfortunately, the owner had received the product from a veterinarian without any further instructions on fasting as recommended by the manufacturer, so the dog was fed prior to Profender® administration. Neurological toxicity included generalized tremor, agitation and panting, and required hospitalization of the dog. All neurological signs resolved after symptomatic treatment within 24 h and the dog was discharged without the need for further medication. MDR1 genotyping revealed a homozygous mutation of the MDR1 gene, which is normally important to prevent brain penetration of emodepside by an efflux-based transport mechanism at the blood brain barrier. This case indicates that Profender® can lead to serious, but transient neurological toxicity in dogs with homozygous MDR1 mutation even at therapeutic dosage, in particular when fasting recommendations are disregarded. Therefore, the case report highlights both the importance of MDR1 genotyping in predisposed dog breeds as well as strict compliance with fasting recommendations around the time of Profender® administration.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.3389/fvets.2019.00296